GGrantIndex
Sort

64,565 grants matching drug discovery

Next generation free energy perturbation (FEP) calculations--enabled by a novel integration of quantum mechanics (QM) with molecular dynamics allowing a large QM region and no sampling compromises

$994,097
David A Pearlman · Quantum Simulation Technologies, Inc. · R44 · FY2025 · GM

Molecular Targets COBRE

$994,005
Donald M Miller · University Of Louisville · P20 · FY2009 · RR

Novel Therapeutic Strategies Targeting Re-emerging Alphaviruses

$993,983
Daniel N Streblow · University Of Alabama At Birmingham · U19 · FY2016 · AI

Discovery of B. pseudomallei therapeutics for Biodefense

$993,879
Donald T Moir · Microbiotix, Inc · R44 · FY2006 · AI

Advancing a novel potent Zika virus specific nucleoside analog to the clinic

$993,605
Klaus Klumpp · Riboscience, Llc · R44 · FY2017 · AI

Midwest Developmental Center for AIDS Research (D-CFAR)

$993,578
Elvin H. Geng · Washington University · P30 · FY2025 · AI

A high-throughput platform for crystallography-based fragment screening

$993,537
Ashley M. Deacon · Accelero Biostructures, Inc. · R44 · FY2018 · GM

Microphysiological systems to model vascular malformations

$993,445
Christopher C. W. Hughes · University Of California-Irvine · UG3 · FY2017 · HL

Development of the NephroPlate: A high-throughput kidney-on-a-chip platform for identifying chronic kidney disease therapies

$993,146
Morgan Chandler · Mimetas Us, Inc. · R44 · FY2023 · DK

Non-Clinical Pharmacology of CX-01

$992,960
Galina Vid · Ceramedix Holding, Llc · R44 · FY2025 · AI

Developing novel LOX inhibitors to target chemotherapy resistant TNBC

$992,932
Ozgur Sahin · Loxigen, Inc. · R42 · FY2024 · CA

The Development of a Web-based Data Retrieval System for HIV Therapy Guidance

$992,666
Colombe Chappey · Monogram Biosciences, Inc. · R44 · FY2007 · AI

Genital Herpes Vaccine Discovery

$992,626
Gary Fujii · Molecular Express, Inc. · R44 · FY2008 · AI

Core G: Computation

$992,467
John A Gerlt · University Of Illinois At Urbana-Champaign · U54 · FY2012 · GM

Core G: Computation

$992,467
John A Gerlt · University Of Illinois At Urbana-Champaign · U54 · FY2011 · GM

Bay Area Cancer Target Discovery and Development

$992,465
Michael T McManus · University Of California, San Francisco · U01 · FY2025 · CA

Systems Biology based Proteogenomic Translator for Cancer Marker Discovery towards Precision Medicine

$992,364
Pei Wang · Icahn School Of Medicine At Mount Sinai · U24 · FY2018 · CA

Parent Project - Main Theme (MAIN)

$992,348
Mark J Ratain · University Of Chicago · U01 · FY2012 · GM

InflammaGut: a drug-screenable co-culture system using gut-associated lymphocytes and autologous primary human gut epithelium that reports inflammation

$992,302
Bill Thelin · Altis Biosystems, Inc. · R44 · FY2022 · TR

Preclinical development of a potent D-peptide RSV inhibitor

$992,263
Brett D Welch · Navigen, Inc. · R44 · FY2016 · AI

Agonists of the RIG-I Innate Immune Pathway

$992,047
Shawn Patrick Iadonato · Kineta, Inc. · R44 · FY2011 · AI

KL4 Surfactant to Mitigate Radiation-Induced Lung Injury

$992,017
Robert Segal · Discovery Laboratories, Inc. · R44 · FY2015 · AI

Targeting the checkpoint regulator VISTA for treatment of inflammatory disease

$991,804
Jay L Rothstein · Immunext, Inc. · R44 · FY2017 · AI

MIN-REACH Research Evaluation and Commercialization Hub

$991,667
Vadim J. Gurvich · University Of Minnesota · U01 · FY2017 · HL

Washington Entrepreneurial Research Evaluation and Commercialization Hub

$991,450
Rodney J.y. Ho · University Of Washington · U01 · FY2019 · HL